Trials / Completed
CompletedNCT01107314
Vasopressin Deficiency in Hemorrhagic Shock
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 98 Years
- Healthy volunteers
- Not accepted
Summary
In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.
Detailed description
This is a prospective observational study. The only research-driven procedure will be the removal of blood samples at designated time points(total blood removed 48 cc per patient). Hemodynamic, fluid infusion and agitation/pain data (RAMSEY Score) will prospectively be collected for research purposes. We will collect data from a convenience sample of patients (when research staff is available) over a one year period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Phlebotomy | Blood draws (total 48 cc blood) |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-04-30
- Completion
- 2011-04-30
- First posted
- 2010-04-20
- Last updated
- 2018-01-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01107314. Inclusion in this directory is not an endorsement.